Clinical Trials

Study Title

informCLL: A Disease Registry for Patients with Chronic Lymphocytic Leukemia

Purpose

To describe current treatment patterns in the real-world setting among CLL patients who are beginning treatment with approved oral kinase inhibitors or other approved anti-CLL therapies/regimens as well as any association with patient characteristics, healthcare resource utilization, clinical outcomes, & patient-reported outcomes.

Eligibility

Study Process